One of the companies that could be of interest to investors at this point in time is Ethema Health Corporation (OTCMKTS:GRST), which is involved in the behavioral healthcare industry and is mainly engaged in providing treatment for substance abuse-related disorders.
Over the course of the last decade, the company has been successful in developing and further honing a unique form of treatment for such patients. More importantly, the treatment in question has also managed to find considerable success. The company has also noted that it is going to continue to work on the development of more such treatments for the fast-growing North American market.
The company was in the news last week on November 29 when it filed its financial results for the third fiscal quarter of 2022. There were plenty of bright spots in the financial results and one of those was the continued strong performance of ARIA, the company’s subsidiary unit. During the first nine months of the year, the subsidiary managed to generate an EBITDA of $712,839. On the other hand, its fully owned subsidiary unit PB Billing LLC managed to generate EBIDTA to the tune of $34,579 in the first nine months. It should however be noted that PB Billing had actually started its operations back in May this year.
For the entire company, the EBITDA for the first nine months of the year came in at $898920. However, that was not all, back on November 14, 2022, Ethema also got a notification from the United States Securities and Exchange Commission with regards to its Form 1A.
That was a significant development for the company considering the fact that following that Ethema got the permission to start raising fresh equity as had been requested in the filing. It may be a good time to keep an eye on the stock.